Nuclear Medicine: Page 59

Israeli firm creates unique Mo-99 production process

By AuntMinnie.com staff writers

Researchers at BGN Technologies have developed a method designed to simultaneously produce molybdenum-99 (Mo-99) and other medical isotopes without highly enriched uranium.

June 6, 2019

ANSTO nets funds for nuclear medicine project

By AuntMinnie.com staff writers

The state government of New South Wales in Australia will invest 12.5 million Australian dollars ($8.74 million U.S.) in an initiative to expand and advance nuclear medicine capabilities at the Australian Nuclear Science and Technology Organisation (ANSTO), a major source of radioisotopes.

June 3, 2019

NRC offers options for radiopharmaceutical training

By AuntMinnie.com staff writers

The U.S. Nuclear Regulatory Commission (NRC) has proposed four options relative to current requirements to administer radiopharmaceuticals, including reducing the number of training and experience hours from 700 to 400.

June 3, 2019

NaF-PET/CT rarely finds prostate cancer bone metastases

By Wayne Forrest

Sodium fluoride (NaF) PET/CT rarely adds value for detecting bone metastases in patients with intermediate- and high-risk prostate cancer and normal bone scintigraphy results prior to prostatectomy, according to a study published online May 30 in the Journal of Nuclear Medicine.

June 2, 2019

Lantheus inks radiopharma deal with NanoMab

By AuntMinnie.com staff writers

Lantheus Holdings, the parent company of Lantheus Medical Imaging, has entered into a strategic collaboration and license agreement with biopharmaceutical firm NanoMab Technology to develop next-generation radiopharmaceuticals for immuno-oncology therapies.

May 30, 2019

Deep learning advances SPECT MPI

By AuntMinnie.com staff writers

Using deep learning to analyze upright and supine SPECT myocardial perfusion images (MPI) could improve the diagnosis of obstructive coronary artery disease, according to a multicenter international study published in the May issue of the Journal of Nuclear Medicine.

May 28, 2019

Eden nets funding for Mo-99 reactor

By AuntMinnie.com staff writers

Eden Radioisotopes has signed an investment agreement with oil and gas company Abo Empire to build a medical isotope production reactor in New Mexico. The planned reactor of less than 2 megawatts of power will primarily manufacture molybdenum-99 (Mo-99), the precursor to technetium-99m.

May 21, 2019

Radium awarded radiation shielding patent

By AuntMinnie.com staff writers

Radiation protection technology developer Radium has received a patent from the U.S. Patent and Trademark Office for its ClearView transparent radiation shield.

May 21, 2019

Shine fills out executive lineup

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies has signed Harsh Singh as its chief strategy officer and Nathan Schleifer as general counsel.

May 21, 2019

IMV: PET/CT drives PET scan volume to new heights

By Lorna Young

Procedure volume in the PET market hit the highest level ever in the U.S., with adoption of PET/CT scanners mainly responsible for driving growth. More than 2 million PET scans were performed in the U.S. in 2018, according to a new market research report by IMV Medical Information Division.

May 19, 2019

International Isotopes posts Q1 decreases

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes posted revenue decreases in its first quarter of 2019 (end-March 31).

May 15, 2019

Shine signs Czech license agreement

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies has signed an intellectual property license agreement with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague).

May 15, 2019

Previous Page

Page 59 of 440

Next Page